ROBERT F APPLE
CIK 1054942 · President and CEO · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.24M
Companies
3
Total Filings
60
Lifetime Open-Market Net
-$5.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-09 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −93,159 | -$291.1K | EDGAR |
| 2020-02-21 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +120,385 | -$319.1K | EDGAR |
| 2019-12-11 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | — | -$830.6K | EDGAR |
| 2019-11-13 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +56,555 | -$53.8K | EDGAR |
| 2019-06-14 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +282,534 | $825.0K | EDGAR |
| 2019-06-11 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −93,161 | -$261.8K | EDGAR |
| 2019-06-04 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −52,559 | -$146.6K | EDGAR |
| 2019-02-22 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +181,960 | -$231.2K | EDGAR |
| 2018-08-23 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | — | -$141.0K | EDGAR |
| 2018-06-11 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +273,525 | $738.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.